PB2030: CLINICAL, LABORATORY PROFILE, TREATMENT AND OUTCOME OF PRIMARY AMYLOIDOSIS IN THE ERA OF NOVEL AGENTS: AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA

Detalles Bibliográficos
Autores principales: Sivaprakasam, Y., Kotwal, J., Saraf, A., Gupta, P., Gupta, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431471/
http://dx.doi.org/10.1097/01.HS9.0000850952.10190.d2
_version_ 1784780064573882368
author Sivaprakasam, Y.
Kotwal, J.
Saraf, A.
Gupta, P.
Gupta, N.
author_facet Sivaprakasam, Y.
Kotwal, J.
Saraf, A.
Gupta, P.
Gupta, N.
author_sort Sivaprakasam, Y.
collection PubMed
description
format Online
Article
Text
id pubmed-9431471
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94314712022-08-31 PB2030: CLINICAL, LABORATORY PROFILE, TREATMENT AND OUTCOME OF PRIMARY AMYLOIDOSIS IN THE ERA OF NOVEL AGENTS: AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA Sivaprakasam, Y. Kotwal, J. Saraf, A. Gupta, P. Gupta, N. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431471/ http://dx.doi.org/10.1097/01.HS9.0000850952.10190.d2 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Sivaprakasam, Y.
Kotwal, J.
Saraf, A.
Gupta, P.
Gupta, N.
PB2030: CLINICAL, LABORATORY PROFILE, TREATMENT AND OUTCOME OF PRIMARY AMYLOIDOSIS IN THE ERA OF NOVEL AGENTS: AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA
title PB2030: CLINICAL, LABORATORY PROFILE, TREATMENT AND OUTCOME OF PRIMARY AMYLOIDOSIS IN THE ERA OF NOVEL AGENTS: AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA
title_full PB2030: CLINICAL, LABORATORY PROFILE, TREATMENT AND OUTCOME OF PRIMARY AMYLOIDOSIS IN THE ERA OF NOVEL AGENTS: AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA
title_fullStr PB2030: CLINICAL, LABORATORY PROFILE, TREATMENT AND OUTCOME OF PRIMARY AMYLOIDOSIS IN THE ERA OF NOVEL AGENTS: AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA
title_full_unstemmed PB2030: CLINICAL, LABORATORY PROFILE, TREATMENT AND OUTCOME OF PRIMARY AMYLOIDOSIS IN THE ERA OF NOVEL AGENTS: AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA
title_short PB2030: CLINICAL, LABORATORY PROFILE, TREATMENT AND OUTCOME OF PRIMARY AMYLOIDOSIS IN THE ERA OF NOVEL AGENTS: AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA
title_sort pb2030: clinical, laboratory profile, treatment and outcome of primary amyloidosis in the era of novel agents: an experience from a tertiary care hospital in india
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431471/
http://dx.doi.org/10.1097/01.HS9.0000850952.10190.d2
work_keys_str_mv AT sivaprakasamy pb2030clinicallaboratoryprofiletreatmentandoutcomeofprimaryamyloidosisintheeraofnovelagentsanexperiencefromatertiarycarehospitalinindia
AT kotwalj pb2030clinicallaboratoryprofiletreatmentandoutcomeofprimaryamyloidosisintheeraofnovelagentsanexperiencefromatertiarycarehospitalinindia
AT sarafa pb2030clinicallaboratoryprofiletreatmentandoutcomeofprimaryamyloidosisintheeraofnovelagentsanexperiencefromatertiarycarehospitalinindia
AT guptap pb2030clinicallaboratoryprofiletreatmentandoutcomeofprimaryamyloidosisintheeraofnovelagentsanexperiencefromatertiarycarehospitalinindia
AT guptan pb2030clinicallaboratoryprofiletreatmentandoutcomeofprimaryamyloidosisintheeraofnovelagentsanexperiencefromatertiarycarehospitalinindia

Ejemplares similares